These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7000349

  • 1. Tamoxifen: an overview of recent studies in the field of oncology.
    Patterson JS, Battersby LA.
    Cancer Treat Rep; 1980; 64(6-7):775-8. PubMed ID: 7000349
    [Abstract] [Full Text] [Related]

  • 2. An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
    Robustelli della Cuna G, Zanon P, Pavesi L, Preti P, Prada GA, Decensi A.
    Chemioterapia; 1986 Jun; 5(3):164-72. PubMed ID: 2941173
    [Abstract] [Full Text] [Related]

  • 3. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M, Kodama T.
    In Vivo; 2001 Jun; 15(4):319-25. PubMed ID: 11695224
    [Abstract] [Full Text] [Related]

  • 4. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE.
    Cancer; 2004 Sep 15; 101(6):1311-22. PubMed ID: 15368322
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
    Wheler J, Johnson M, Seidman A.
    Semin Oncol; 2006 Dec 15; 33(6):672-80. PubMed ID: 17145347
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
    Azria D, Lemanski C, Zouhair A, Gutowski M, Belkacémi Y, Dubois JB, Romieu G, Ozsahin M.
    Cancer Radiother; 2004 Jun 15; 8(3):188-96. PubMed ID: 15217586
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R.
    Eur J Surg Oncol; 2008 Jul 15; 34(7):746-55. PubMed ID: 18296017
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adjuvant treatment of breast cancer.
    Akerley WL.
    R I Med; 1995 Sep 15; 78(9):250-3. PubMed ID: 7579720
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M.
    Cancer Res; 1999 Aug 01; 59(15):3646-51. PubMed ID: 10446976
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
    Marcsek Z, Kocsis Z, Jakab M, Szende B, Tompa A.
    Cancer Biother Radiopharm; 2004 Dec 01; 19(6):746-53. PubMed ID: 15665622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.